Tanzania (Mainland) Neglected Tropical Diseases Master Plan (2021 - 2026)

The Master plan addresses 5 PCT targeted NTDs as guided by HSSP V 2021 - 2026. The HSSP V 2021-2026 states application of Mass Drug Administration (MDA), Environmental Interventions and Case and Co-morbidities management, for for Lymphoedema, Hydrocele and Trachomatous Trichiasis as the key interventions for implementation of control and elimination of 5 PC-NTDs under the NTD Programme. 

The main goal of the previous plan was to reduce morbidity due to NTDs in Tanzania to a level that they are no longer a public health problem by 2017 through community and school-based delivery mechanisms. 

1. Significant achievements have been realized in the past eleven years since the launching of the integrated NTD control program. These achievements have come due to collaborative effort of local communities, government, partners and implementing team. Some of these successes include Establishing and implementing integrated NTD control. Tanzania is one of the first WHO African region countries to integrate the coordination and implementation of 5 PC-NTDs diseases control /elimination activities, including MDA, health education and morbidity management.
2. Inclusion of NTD in the Health Strategic Plans and its budget tools. NTDs was included in the HSSPIV (2016-2020) and the Council Comprehensive health plans (CCHP).
3. Attainment of full (100%) geographical coverage for MDA in all councils. MDA for onchocerciasis reached full coverage by 2009, for LF in 2014 and for STH and SCH in 2015/16. In 2013 over 19 million people were treated with 45 million treatments and in 2014, over 23 million people were reached with 55 million treatments of Ivermectin, Albendazole, Praziquantel and Zithromax. In 2016/17, over 17.4 million people were reached with 34.9 million treatments of the same medicines. MOHCDGEC | Tanzania Mainland NTD Country Master Plan: 2021-2026 12
4. Scaling down of MDA for LF and trachoma: For Lymphatic Filariasis the country scaled down from the previous 119 endemic districts that needed MDA to 24 (80% reduction) in 2019 and for Trachoma the country scaled down from the previous 71 districts that needed MDA to 6 (92% reduction) districts that needed MDA in 2019.